» Articles » PMID: 35977967

Differential Gene Expression in IPSC-derived Human Intestinal Epithelial Cell Layers Following Exposure to Two Concentrations of Butyrate, Propionate and Acetate

Overview
Journal Sci Rep
Specialty Science
Date 2022 Aug 17
PMID 35977967
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal epithelial cells and the intestinal microbiota are in a mutualistic relationship that is dependent on communication. This communication is multifaceted, but one aspect is communication through compounds produced by the microbiota such as the short-chain fatty acids (SCFAs) butyrate, propionate and acetate. Studying the effects of SCFAs and especially butyrate in intestinal epithelial cell lines like Caco-2 cells has been proven problematic. In contrast to the in vivo intestinal epithelium, Caco-2 cells do not use butyrate as an energy source, leading to a build-up of butyrate. Therefore, we used human induced pluripotent stem cell derived intestinal epithelial cells, grown as a cell layer, to study the effects of butyrate, propionate and acetate on whole genome gene expression in the cells. For this, cells were exposed to concentrations of 1 and 10 mM of the individual short-chain fatty acids for 24 h. Unique gene expression profiles were observed for each of the SCFAs in a concentration-dependent manner. Evaluation on both an individual gene level and pathway level showed that butyrate induced the biggest effects followed by propionate and then acetate. Several known effects of SCFAs on intestinal cells were confirmed, such as effects on metabolism and immune responses. The changes in metabolic pathways in the intestinal epithelial cell layers in this study demonstrate that there is a switch in energy homeostasis, this is likely associated with the use of SCFAs as an energy source by the induced pluripotent stem cell derived intestinal epithelial cells similar to in vivo intestinal tissues where butyrate is an important energy source.

Citing Articles

The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation.

Yu W, Sun S, Fu Q Front Immunol. 2025; 16:1519925.

PMID: 39991152 PMC: 11842938. DOI: 10.3389/fimmu.2025.1519925.


Nutrigenomic underpinnings of intestinal stem cells in inflammatory bowel disease and colorectal cancer development.

Ho J, Puoplo N, Pokharel N, Hirdaramani A, Hanyaloglu A, Cheng C Front Genet. 2024; 15:1349717.

PMID: 39280096 PMC: 11393785. DOI: 10.3389/fgene.2024.1349717.


Novel Role of the Gene Associated with Constipation Caused by Complement Component 3 Deficiency.

Song H, Kim J, Roh Y, Seol A, Kim T, Park K Int J Mol Sci. 2024; 25(17).

PMID: 39273477 PMC: 11395586. DOI: 10.3390/ijms25179530.


Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.

Walraven T, Busch M, Wang J, Donkers J, Duijvestein M, van de Steeg E Arch Toxicol. 2024; 98(11):3519-3541.

PMID: 39249550 PMC: 11489187. DOI: 10.1007/s00204-024-03844-w.


Transport of perfluoroalkyl substances across human induced pluripotent stem cell-derived intestinal epithelial cells in comparison with primary human intestinal epithelial cells and Caco-2 cells.

Janssen A, Duivenvoorde L, Beekmann K, Pinckaers N, van der Hee B, Noorlander A Arch Toxicol. 2024; 98(11):3777-3795.

PMID: 39215840 PMC: 11489206. DOI: 10.1007/s00204-024-03851-x.


References
1.
LeBlanc J, Milani C, Savoy de Giori G, Sesma F, Van Sinderen D, Ventura M . Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol. 2012; 24(2):160-8. DOI: 10.1016/j.copbio.2012.08.005. View

2.
Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F . From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016; 165(6):1332-1345. DOI: 10.1016/j.cell.2016.05.041. View

3.
Cummings J, Pomare E, Branch W, Naylor C, Macfarlane G . Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987; 28(10):1221-7. PMC: 1433442. DOI: 10.1136/gut.28.10.1221. View

4.
Saemann M, Bohmig G, Osterreicher C, Burtscher H, Parolini O, Diakos C . Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 2000; 14(15):2380-2. DOI: 10.1096/fj.00-0359fje. View

5.
Maa M, Chang M, Hsieh M, Chen Y, Yang C, Chen Z . Butyrate reduced lipopolysaccharide-mediated macrophage migration by suppression of Src enhancement and focal adhesion kinase activity. J Nutr Biochem. 2010; 21(12):1186-92. DOI: 10.1016/j.jnutbio.2009.10.004. View